RxDoctor Payments DataLook up a doctor →

Martin Schuster

Psychiatry · Sherman Oaks, CANPI 1114973203

Payments from drug & device makers

$4,968,700in general payments, 2019–2025

Across 973 payments — averaging $5106.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2M
  • Sunovion Pharmaceuticals Inc.$1.6M
  • Hoffmann-la Roche Limited$496K
  • Merck$442K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$182K
  • Boehringer Ingelheim$125K
  • plus $122K from 18 others
$1,406,764in research payments, 2019–2025

Across 101 payments — averaging $13,928 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Teva Pharmaceuticals USA, Inc.$1.4M
  • Eli Lilly$409

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,968,700 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Other psychiatry in Sherman Oaks

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →